Dinah W.Y. Sah

Port Washington Public Library — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

42h-index14.5kcitations94works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(31), Nerve injury and regeneration(16), Advanced biosensing and bioanalysis techniques(14), MicroRNA in disease regulation(12), Neurogenesis and neuroplasticity mechanisms(12)

Publications94 total

Exacerbation of a Subset of Behavioral Phenotypes by Early Treatment with AAV FOXG1 Gene Replacement Therapy in a Mouse Model of FOXG1 Syndrome
2025
Serum Sodium in Acute Stroke and its Clinical Correlation
Med Phoenix·2024Open Access
Pharmacokinetics and Pharmacodynamics of an Antibody Targeting Pathological Tau for the Treatment of Alzheimer’s Disease: Nonclinical Studies in P301S Mice and Cynomolgus Macaques
Alzheimer s & Dementia·2024· 1 citedOpen Access
The Role Of Serum 25 Hydroxy Vitamin D Level, Lipid Profile And Blood Glucose Level In Diagnosed Case Of Osteoporosis
International Journal of Research in Medical Sciences & Technology·2024Open Access
Data from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
2023Open Access
Supplementary Tables from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
2023Open Access
Supplementary Tables from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
2023Open Access
Data from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
2023Open Access
Supplementary Methods and Legends from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
2023Open Access
Supplementary Methods and Legends from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
2023Open Access
Supplementary Figures from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
2023Open Access
Supplementary Figures from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
2023Open Access
Efficient and Precise Processing of the Optimized Primary Artificial MicroRNA in a Huntingtin-Lowering Adeno-Associated Viral Gene Therapy <i>In Vitro</i> and in Mice and Nonhuman Primates
Human Gene Therapy·2021· 9 citedOpen Access
Creating a STEM-based Economic Pillar for the Caribbean: A Blueprint
Journal of Education and Development in the Caribbean·2019· 2 cited
Erratum: Gene therapy for neurological disorders: progress and prospects
Nature Reviews Drug Discovery·2018· 254 citedOpen Access
Gene therapy for neurological disorders: progress and prospects
Nature Reviews Drug Discovery·2018· 293 cited
Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides
Nature Biotechnology·2017· 358 cited
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis
Amyloid·2016· 114 citedOpen Access
86. Comparison of CNS Transduction by Different AAV Capsids in Mouse and Non-Human Primate
Molecular Therapy·2015Open Access
195. Comparative Analysis In Vitro of Regulatory Elements That Drive Targeted Gene Expression in Adenovirus-Associated Viral (AAV) Vectors
Molecular Therapy·2015Open Access
page 1 of 5Next →

Frequent Co-authors

Muthiah Manoharan(10), Kallanthottathil G. Rajeev(7), Lubomir V. Nechev(6), Martin A. Maier(6), Qingmin Chen(6), June Qin(5), Rene Alvarez(5), William Querbes(5), Lee Walus(5), Anthony Rossomando(5), Pei Ge(5), Akin Akinc(4), J. Robert Dorkin(4), Todd Borland(4), Antonin de Fougerolles(4), Victor Koteliansky(4), James S. Butler(4), Kevin Fitzgerald(4), Rachel Meyers(4), Renta Hutabarat(4)